bromhexine has been researched along with Pharyngitis in 2 studies
Bromhexine: A mucolytic agent used in the treatment of respiratory disorders associated with viscid or excessive mucus. (From Martindale, The Extra Pharmacopoeia, 30th ed, p744)
bromhexine : A substituted aniline that is 2,4-dibromoaniline which is substituted at position 6 by a [cyclohexyl(methyl)amino]methyl group. It is used (as the monohydrochloride salt) as a mucolytic for the treatment of respiratory disorders associated with productive cough (i.e. a cough characterised by the production of sputum).
Pharyngitis: Inflammation of the throat (PHARYNX).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pennacchio, G | 1 |
| Manfredi, G | 1 |
| Szabadka, H | 1 |
2 other studies available for bromhexine and Pharyngitis
| Article | Year |
|---|---|
[The feprazone-bromhexine association in pediatric bronchopneumopathies].
Topics: Bromhexine; Bronchitis; Bronchopneumonia; Child; Child, Preschool; Drug Combinations; Drug Evaluatio | 1978 |
Clinical observations with Paxirasol nasal spray.
Topics: Administration, Intranasal; Adult; Aged; Aged, 80 and over; Bromhexine; Female; Humans; Intubation; | 1992 |